Alkem Laboratories Ltd.NSE: ALKEM

Press Release Jun 02 2026

· Issued by Alkem Laboratories Ltd. via NSE India

Filed with NSE · · 3 pages · English

Release

Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".

Alkem Laboratories Ltd. on 6ix

Earlier from Alkem Laboratories

Later from Alkem Laboratories

All Alkem Laboratories news releases